Pharma Mar SA

Pharma Mar SA financial statements

Pharma Mar SA's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueEUR 221.39MAnnual report
Net incomeEUR 74.99MAnnual report
Cash and equivalentsEUR 17.82MAnnual report
Total debtEUR 38.57MAnnual report

Pharma Mar SA financials on 6ix · Pharma Mar SA on 6ix